OXIG
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Oxford Instruments plc is a technology company that provides high-technology products and services for research and industry. The group serves academic and commercial partners globally, offering expertise and equipment for scientific and industrial applications.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Scientific & Technical Instruments Homepage oxinst.com
Sector Technology IR page oxinst.com/investors-hub
Tags
scientific instruments, research equipment, industrial technology, academic services
Press page oxinst.com/news

Metrics

Valuation  
Market cap £ 1.668B
Market cap (USD) $ 2.207B
P/E 31.06
PEG —
P/BV 4.90
P/S 3.80
P/OCF 30.67
P/FCF 35.50
Dividend yield 0.78%
Turnover / mcap —
Returns  
ROE 13.5%
ROI 14.2%
ROIC 13.0%
Profit margin 11.4%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -8.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 0.06%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 30
Quality score -5.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 423.2M 500.6M 470.4M 444.7M 367.3M 318.5M 317.4M 296.9M 296.9M 300.2M 361.6M 348.5M 360.1M 350.8M 2.623B 2.623B 2.115B
Net profit 48.2M 26M 50.7M 58.6M 38.6M 41.8M 33.8M 30M 65.5M -20.3M 7M -6.3M 18.2M — — — —
Free cash flow 47M 34.7M 15.4M 34.2M 35.2M 37.6M — — — — — — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 19.42 24.2 20.21 22.05 25.48 — — — — — — — — — — — —
Price performance 12m -0.2 0.2 -0.08 -0.13 — — — — — — — — — — — — —

Filed figures

Figure Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (GBP) 75.6M 105M 113M 115M 126M 125M
↳ YoY growth +38.5% +8.1% +1.3% +10.0% -1.0%
↳ 5y CAGR +10.6%
Borrowings, current (GBP) 30.4M 9.2M 11.6M 13.1M 9.2M 12.7M
Borrowings, non-current (GBP) 0.00 1.3M 900,000 900,000 500,000 200,000
Lease liabilities (GBP) 7.5M 18.4M 31.4M 33.4M 31.2M 31.6M
Cash and deposits (GBP) 128M 96.4M 113M 97.8M 94.1M 107M
Right-of-use assets (GBP) 7.3M 17.9M 31.4M 32.4M 29.9M 29.9M
Net debt (borrowings + leases - cash) (GBP) -90.1M -67.5M -68.8M -50.4M -53.2M -62.4M
Cash flow detail
Operating cash flow (GBP) 41.8M 49.1M 66.5M 42.4M 49.1M 54.4M
Purchases of property, plant and equipment (GBP) -4.2M -13.9M -32.3M -27M -14.4M -7.4M
Purchases of intangible assets (GBP) 0.00 -100,000 0.00 — 0.00 -500,000
Change in receivables (cash effect) (GBP) -10.5M -21.6M -19.6M -2.7M -10M -20.9M
Change in inventories (cash effect) (GBP) -1.3M -100,000 -15.6M -26.3M 8.8M -1.6M
Dividends paid (cash effect) (GBP) 0.00 -12.3M -10.6M -11.4M -12.1M -13M
Share buybacks (cash effect) (GBP) — — — — 0.00 -62.2M
Interest paid (cash effect) (GBP) -1.6M -500,000 -1.2M -1.7M -1.2M —
Income taxes paid (cash effect) (GBP) -6.3M -8.8M -5.7M -16.1M -19.8M -11.1M
Operating cash flow before change in receivables (GBP) 52.3M 70.7M 86.1M 45.1M 59.1M 75.3M
Free cash flow (OCF - PPE - intangibles) (GBP) 37.6M 35.1M 34.2M 15.4M 34.7M 46.5M
Income detail
Research and development expense (GBP) 31.3M 32.8M 36.7M 39.1M 41.1M 37.1M
↳ 5y CAGR +3.5%
Comprehensive income to owners (GBP) 11.6M 60.1M 35M 30.6M 23.1M 35.3M
Reported Jun 29, 2022 Jun 29, 2022 Jul 20, 2023 Jun 25, 2024 Jun 23, 2026 Jun 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Half-Year Results Bull 2 Bear 0 Results

Oxford Instruments plc, a leading provider of scientific technology and expertise to commercial and academic partners, is today issuing a trading update for the six months ended 30 September 2026. 

The period saw strong demand across both divisions, with Group order intake up nearly 44%. Reported revenue grew by approximately 8% (+9% OCC1) in the first half, and adjusted operating margin is expected to progress by over 100 bps versus the prior year period. The strength of order intake and resulting orderbook cover for H2 underpins the Group’s confidence in delivering full year results in line with market expectations2. 

The Imaging and Analysis division saw strong growth in order intake in H1, up over 11% versus the prior year, driven by demand for semiconductor and materials science applications. Total order book for the division grew c. 5% versus H1 FY26. Revenue growth was c. 2-3% as some of the smaller product lines replenished orderbook during H1 following a high level of deliveries in Q4 FY26. The division continues to show good progress over FY26, with revenue growth for the full year expected to be in line with guidance. Adjusted operating margin for this division improved following a challenging H1 FY26, and we continue to invest to support growth and manage external macro risks.

Order growth in the Advanced Technologies division was very strong, up over 125% versus the prior year. Around three quarters of H1 order intake was driven by demand for datacom applications following a number of commercial volume manufacturing customer wins. The current orderbook now extends well into FY28, with expected revenue fully covered for FY27.

Advanced Technologies revenue grew by c. 26% in H1 as the business expanded production capacity in both the facility and supply chain to meet increasing demand. Despite increased investment to support this expansion, adjusted operating margin has materially improved versus the prior year. 

Cash conversion has significantly improved versus prior periods as a result of an improved working capital movement which, along with a reduction in adjusting items and the elimination of pension contributions, has had a very positive impact on free cash flow versus the prior year. Net cash at the end of the period was £75m (H1 FY26: £45.1m). 

As at 30 September 2026 £83m of the £100m share buyback programme had been completed. The programme is expected to fully complete early in the new year.

Richard Tyson, CEO, commented:

_“We have made further strong progress in the first half - executing on our strategy, delivering for our customers and building momentum across both our businesses.

“I am really pleased to see the positive order momentum in H1 in Imaging and Analysis, continuing the solid recovery we saw in H2 last year, supported by both investment in the front end of the organisation, and by our teams actively managing macro execution risks.

“Advanced Technologies order intake has been outstanding, growing even faster than expected, and we are winning multiple new customers thanks to our differentiated process and platform technology. I’m also very pleased to see the positive order growth feeding through to revenue and margin. Our focus this year is on investing in ramping our capacity, supply chain and service model to deliver for customers and cement our position in this rapidly growing market.”_

Notice of Interim FY27 results
Oxford Instruments management will present the Group’s half-year results to analysts and investors at Deutsche Numis, 21 Moorfields, London, EC2Y 9DB on 10 November 2026.

Notes

1. Organic constant currency (OCC)

2. Mean of Consensus estimates for FY27: Revenue £444.4m, Adjusted Operating Profit £81.0m.

The financial information in this trading update is unaudited.

LEI: 213800J364EZD6UCE231

Related News

[Oct 13, 2026
\

Interim trading update: Strong demand across both divisions underpins confidence in full-year expectations\


Oxford Instruments plc, a leading provider of scientific technology and expertise to commercial and academic partners, is today issuing a trading update…

Read full article >](https://www.oxinst.com/news/interim-trading-update-strong-demand-across-both-divisions-underpins-confidence-in-full-year-expectations/) [Sep 29, 2026
\

Oxford Instruments partners with Hakuto to expand advanced plasma processing capabilities across Japan\


Oxford Instruments is pleased to announce the appointment of Hakuto Co., Ltd. as its compound semiconductor equipment distributor in Japan, strengthening…

Read full article >](https://www.oxinst.com/news/oxford-instruments-partners-with-hakuto-to-expand-advanced-plasma-processing-capabilities-across-japan/) [Sep 24, 2026
\

Oxford Instruments launches global Insight Awards 2026\


Oxford Instruments has today announced the launch of its Insight Awards, a global awards programme recognising outstanding achievements, discoveries and…

Read full article >](https://www.oxinst.com/news/oxford-instruments-launches-global-insight-awards-2026/)

View More

Open in a new tab

Oxford Instruments

© Oxford Instruments 2026

Prompts

Oxford Instruments plc (ticker OXIG), listed in United Kingdom.

ETFs Holding Oxford Instruments plc

ETF Weight in ETF Shares Market value As of
AVDS 0.07% 7,979 $ 263.449K Nov 16, 2026
DFIS 0.02% 36,990 $ 1.296M Nov 12, 2026
AVSD 0.01% 1,433 $ 47.314K Nov 16, 2026
AVDE 0.00% 12,234 $ 403.939K Nov 16, 2026